What are the diagnostic criteria and treatment approaches for Substance Use Disorder (SUD) according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DSM-5 Diagnostic Criteria for Substance Use Disorder

According to the DSM-5, Substance Use Disorder (SUD) is diagnosed when a patient meets at least two out of eleven criteria within a 12-month period, with severity classified as mild (2-3 criteria), moderate (4-5 criteria), or severe (6+ criteria). 1

Diagnostic Criteria

The DSM-5 combines the previously separate DSM-IV diagnoses of substance abuse and substance dependence into a single disorder measured on a continuum of severity. The eleven criteria for SUD include:

  1. Impaired control:

    • Taking the substance in larger amounts or over longer periods than intended
    • Persistent desire or unsuccessful efforts to cut down or control use
    • Spending a great deal of time obtaining, using, or recovering from substance use
    • Craving or strong desire to use the substance
  2. Social impairment:

    • Recurrent use resulting in failure to fulfill major role obligations
    • Continued use despite persistent social or interpersonal problems caused by use
    • Important social, occupational, or recreational activities given up because of use
  3. Risky use:

    • Recurrent use in physically hazardous situations
    • Continued use despite knowledge of physical or psychological problems likely caused by the substance
  4. Pharmacological criteria:

    • Tolerance (needing increased amounts for same effect)
    • Withdrawal symptoms when not using

Severity Classification

  • Mild: 2-3 criteria met
  • Moderate: 4-5 criteria met
  • Severe: 6 or more criteria met 1

Important Diagnostic Considerations

  • Medical use exception: When substances are used appropriately under medical supervision (e.g., opioids for pain), tolerance and withdrawal alone do not qualify for an SUD diagnosis 1

  • Craving criterion: The addition of craving as a criterion in DSM-5 helps identify cases but doesn't substantially affect overall diagnosis rates 2

  • Diagnostic orphans: DSM-5's lower threshold (2+ criteria) captures individuals who previously fell between diagnostic categories in DSM-IV 3

Course Specifiers

DSM-5 includes important course specifiers:

  • Early remission: 3-12 months without meeting SUD criteria (except craving)
  • Sustained remission: 12+ months without meeting SUD criteria (except craving)
  • In a controlled environment: When access to substances is restricted
  • On maintenance therapy: For patients on medications like methadone, buprenorphine, naltrexone, or tobacco cessation medications 1

Screening Tools

For initial screening, clinicians can use:

  1. Single-question screen: "How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?" (90-100% sensitivity) 1

  2. Drug Abuse Screening Test (DAST-10): 10-item questionnaire with excellent sensitivity (90-100%) for identifying substance abuse or dependence 1

Treatment Approaches

Treatment should be matched to the severity of the disorder:

For Mild SUD (2-3 criteria):

  • Brief counseling using motivational interviewing techniques
  • Ongoing assessment and monitoring 1

For Moderate SUD (4-5 criteria):

  • Brief counseling with a negotiated treatment plan
  • Close follow-up
  • Referral for more intensive treatment if symptoms persist 1

For Severe SUD (6+ criteria):

  • Brief counseling with referral for specialized treatment
  • Consider medication-assisted treatment when appropriate
  • Ongoing assessment and support 1

Medication-Assisted Treatment

For opioid use disorder specifically, evidence-based treatment typically includes:

  • Buprenorphine or methadone maintenance therapy
  • Behavioral therapies in combination with medications
  • Regular monitoring and follow-up 1, 4

Clinical Pearls and Pitfalls

  • Avoid diagnostic errors: Don't diagnose SUD based solely on tolerance and withdrawal in patients appropriately using prescribed medications 1

  • Recognize comorbidities: SUDs frequently co-occur with other mental health disorders, requiring comprehensive assessment 5

  • Monitor treatment progress: Assess for abstinence from illicit substances, medication compliance, and engagement in recovery activities 4

  • Prevent relapse: When discontinuing treatment, implement a gradual taper and comprehensive relapse prevention plan 4

  • Screening implementation: The Substance Use Symptom Checklist has been validated for assessing DSM-5 SUD symptoms in primary care settings 6

By understanding and applying these DSM-5 criteria systematically, clinicians can more accurately diagnose SUDs and implement appropriate evidence-based treatments to improve patient outcomes.

Related Questions

What are the strengths and weaknesses of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, Eleventh Revision (ICD-11) in diagnosing substance abuse, and what improvements can be made to these systems for clinical work and research?
What treatment approach is recommended for a younger to middle-aged adult with a history of substance use disorder and psychological factors, as per DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) diagnosis, but no formal psychiatric diagnosis?
What are the diagnostic changes for stimulant‑related disorders across the Diagnostic and Statistical Manual of Mental Disorders (DSM) versions III, III‑TR, IV, V, and V‑TR, and the International Classification of Diseases (ICD) versions X and XI?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) and International Classification of Diseases, 11th Revision (ICD-11) for diagnosing substance use disorders, and how can they be improved?
What are the strengths and weaknesses of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM‑5‑TR) and the International Classification of Diseases, Eleventh Revision (ICD‑11) in diagnosing opioid‑related disorders?
What dose of elemental iron is required to increase hepcidin levels?
What is the best site for emergency dialysis catheter placement?
What are the contraindications for administering epinephrine (adrenaline) during cardiopulmonary resuscitation (CPR)?
What is the best medication for pulmonary embolism (PE) in pregnancy?
What modifications are needed if a patient has a hemoglobin A1c (HbA1c) level outside of target due to central apneas?
What are the steps for diagnosing and treating HIV (Human Immunodeficiency Virus) infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.